Home
Translumina GmbH

Translumina GmbH Market Share Analysis for June 2026

Translumina, one of the top global interventional cardiovascular device companies, is among the leading cardiac stent manufacturers, committed to delivering best stent.

Industry: N/A

Domaintranslumina.com

Year Founded2000

Employees501 - 1000

Annual Revenue--

Translumina GmbH

Translumina GmbH (including company regionals)

translumina.com

See more website traffic and engagement information

Total visits to Translumina GmbH's top domains

Understand Translumina GmbH market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

translumina.com11.8K

See more with Sales Intelligence

Avg. visit duration in Translumina GmbH's top domains

Analyze Translumina GmbH engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

translumina.com00:00:26

See more with Sales Intelligence

Avg. pageviews on Translumina GmbH's top domains

See how Translumina GmbH keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

translumina.com2.00

See more with Sales Intelligence

Translumina GmbH top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Translumina GmbH

These are the website technologies, by industry, used by Translumina GmbH top domains

Widget (8)

Twemoji

Social (3)

Instagram

Content Management System (2)

WordPress

Conversion & Analytics (2)

Google Analytics

More Technologies

7

See all

News & Signals from Translumina GmbH

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsTranslumina GmbH launched VIVO ISAR on Apr 1st '25.* In April 2025, Translumina, a global developer and manufacturer of innovative cardiovascular medical devices used in interventional cardiology, announced the launch of VIVO ISAR, its latest generation dual drug polymer-free coated stent (DDCS), in various international markets, including Europe.

NewsEwopharma AG partnered with Translumina GmbH on Jun 1st '24.Ewopharma AG has secured an exclusive distribution agreement for advanced cardiovascular solutions with Translumina, effective June 1, 2024.

NewsTranslumina GmbH acquired Blue Medical Tower on Sep 21st '23.Last year, Translumina acquired Blue Medical, a Dutch medical device company renowned for specializing in drug-coated balloons, and Lamed, a leading player in the vascular surgery market in Germany, further enhancing the company's product offerings.